UK
UK
Jan-21
Hepatology Oncology Pharmacoepidemiology
Read moreDec-20
Dec-20
Cardiovascular Pharmacoepidemiology
Read moreDec-20
Pharmacoepidemiology Respiratory
Read moreDec-20
Dermatology Pharmacoepidemiology
Read moreDec-20
Pharmacoepidemiology Respiratory
Read moreDec-20
Cardiovascular Pharmacoepidemiology
Read moreDec-20
Cardiovascular Gastroenterology Pharmacoepidemiology
Read moreNov-20
Gastroenterology Oncology Pharmacoepidemiology
Read moreNov-20
Gastroenterology Pharmacoepidemiology
Read moreNov-20
Nov-20
Cardiovascular Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Jan-21 | Digoxin use is associated with pancreatic cancer risk but does not affect survival | Read more | |
| Dec-20 | Identifying diabetes types by modelling drug consumption and patient profile data from pharmacies | Read more | |
| Dec-20 | Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke | Read more | |
| Dec-20 | Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK | Read more | |
| Dec-20 | Treatment patterns in UK adult patients with atopic dermatitis treated with systemic immunosuppressants: data from The Health Improvement Network (THIN) | Read more | |
| Dec-20 | Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease | Read more | |
| Dec-20 | Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance | Read more | |
| Dec-20 | Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study | Read more | |
| Nov-20 | Low-dose aspirin and risk of gastric and oesophageal cancer: a population-based study in the United Kingdom using The Health Improvement Network | Read more | |
| Nov-20 | Bleeding associated with low-dose aspirin: Comparison of data from the COMPASS randomized controlled trial and routine clinical practice | Read more | |
| Nov-20 | Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice | Read more | |
| Nov-20 | Long-term persistence to low-dose aspirin for cardiovascular prevention in routine clinical practice in United Kingdom and Germany | Read more |
